Assumption that the pathogenesis of obesity-associated type 2 diabetes (T2DM) encompasses inflammation and autoimmune aspects is increasingly recognized. In the state of obesity and T2DM, the imbalance of T helper 17 (Th17) cells and regulatory T (Treg) cells are observed. These alterations reflect a loss of T cell homeostasis, which may contribute to tissue and systemic inflammation and immunity in T2DM. In this review we will discuss the accumulating data supporting the concept that Th17/Treg mediated immune responses are present in obesity-related T2DM pathogenesis, and provide evidences that restoration of Th17/Treg imbalance may be a possible therapeutic avenue for the prevention and treatment of T2DM and its complications.
Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients.
Mei Wang,Fuqiong Chen,Jingli Wang,Z. Zeng,Qin Yang,S. Shao
Published 2018 in Clinical Immunology
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Clinical Immunology
- Publication date
2018-12-01
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-99 of 99 references · Page 1 of 1
CITED BY
Showing 1-90 of 90 citing papers · Page 1 of 1